Atlas Trials

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

Clinical trial NCT02596074 · COMPLETED

Trial details

NCT number
NCT02596074
Sponsor
Maruho Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Usual Type Vulval Intraepithelial Neoplasia (uVIN)
Start date
2015-11-01
Primary completion
2017-03-07
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.